Detalhe da pesquisa
1.
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1.
Bioorg Med Chem Lett
; 23(12): 3592-8, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23642482
2.
Identification of imidazo-pyrrolopyridines as novel and potent JAK1 inhibitors.
J Med Chem
; 55(12): 5901-21, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22591402
3.
Discovery and optimization of C-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.
J Med Chem
; 55(13): 6176-93, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22698084
4.
Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABA(A) alpha5 inverse agonist for cognitive dysfunction.
Bioorg Med Chem Lett
; 16(4): 872-5, 2006 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16303300
5.
8-Methoxyquinoline-5-carboxamides as PDE4 inhibitors: a potential treatment for asthma.
Bioorg Med Chem Lett
; 12(12): 1613-5, 2002 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-12039574